Jump Financial’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$514K Buy
+111,117
New +$494K ﹤0.01% 1672
2026
Q1
– Sell
-246,840
Closed -$1.59M – 1867
2025
Q4
$1.59M Buy
246,840
+226,237
+1,098% +$1.41M 0.02% 774
2025
Q3
$115K Buy
+20,603
New +$89.1K ﹤0.01% 1696
2024
Q3
– Sell
-130,920
Closed -$340K – 1624
2024
Q2
$340K Buy
130,920
+99,864
+322% +$334K 0.01% 1326
2024
Q1
$132K Buy
31,056
+1,244
+4% +$4.14K ﹤0.01% 1756
2023
Q4
$60.2K Buy
+29,812
New +$52.7K ﹤0.01% 1701
2021
Q4
– Sell
-49,700
Closed -$216K – 1361
2021
Q3
$216K Buy
49,700
+19,070
+62% +$74.8K 0.02% 830
2021
Q2
$122K Buy
+30,630
New +$122K 0.01% 958

Other funds holding AQST

Jump Financial's AQST Position: Q3 2026 in Review

Jump Financial opened a new position in Aquestive Therapeutics (AQST) in Q3 2026: 111,117 shares worth $514K. The stake represents ﹤0.01% of the portfolio and ranks #1672 among its holdings. This is a return to the name: Jump Financial previously reported a position in AQST as recently as Q4 2025.

Jump Financial first reported a position in AQST in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.59M in Q4 2025. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

  • Jump Financial held 111,117 shares of Aquestive Therapeutics worth $514K as of Q3 2026.
  • Aquestive Therapeutics was a new Jump Financial position in Q3 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #1672 holding.
  • Jump Financial first reported a position in Aquestive Therapeutics in Q2 2021 and has held it in 8 quarters since.
  • Jump Financial's Aquestive Therapeutics position peaked at $1.59M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.